[Background for clinical manifestation of hereditary angioneurotic edema (HANE)]

[Article in Japanese]

[Article in Japanese]

J Kodama. Rinsho Byori. 1983 Aug.

. 1983 Aug;31(8):860-2.

No abstract available

Similar articles

C1-inhibitor in hereditary angioneurotic edema: types I and II.
Donaldson VH. Donaldson VH. Behring Inst Mitt. 1989 Jul;(84):151-60. Behring Inst Mitt. 1989. PMID: 2679530 Review. No abstract available.
Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli.
Kodama J, Uchida K, Yoshimura S, Katayama Y, Kushiro H, Yutani C, Funahashi S, Takamiya O, Matsumoto Y, Ando Y, et al. Kodama J, et al. Blut. 1984 Nov;49(5):405-18. doi: 10.1007/BF00319889. Blut. 1984. PMID: 6388669
[Hereditary angioneurotic edema: pathophysiology and therapy].
Kodama J, Uchida K, Yutani C, Funahashi S. Kodama J, et al. Behring Inst Mitt. 1986 Feb;(79):231-40. Behring Inst Mitt. 1986. PMID: 3521576 German.
Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.
Donaldson VH, Rosen FS, Bing DH. Donaldson VH, et al. Trans Assoc Am Physicians. 1977;90:174-83. Trans Assoc Am Physicians. 1977. PMID: 148134 No abstract available.
C1 inhibitor and hereditary angioneurotic edema.
Davis AE 3rd. Davis AE 3rd. Annu Rev Immunol. 1988;6:595-628. doi: 10.1146/annurev.iy.06.040188.003115. Annu Rev Immunol. 1988. PMID: 3289579 Review. No abstract available.